Antiviral Drugs Market Will Reach US $82.9 Bn by 2024, with Rising Prevalence of HIV/AIDS and Hepatitis
With the significant increase in the incidence of viral infections, the global antiviral drugs market is witnessing a substantial rise in its size and valuation. The increasing prevalence of chronic infections, such as HIV/AIDS and hepatitis B, which require long-term treatment, is also adding considerably to the growth of this market.
View full press release